Recent Blog Articles

Is online gambling harming you?

Preventable liver disease is rising: What you eat — and avoid — counts

Fall shots: Who's most vulnerable to RSV, COVID, and the flu?

Got immunity? Thank your thymus

Easy ways to shop for healthful, cost-conscious foods

When — and how — should you be screened for colon cancer?

7 organs or glands you may do just fine without

How to help your child get the sleep they need

What color is your tongue? What's healthy, what's not?

Immune boosts or busts? From IV drips and detoxes to superfoods

Jessica Allegretti, MD, MPH
Contributor
Jessica Allegretti, MD, MPH, graduated from Cornell University in Ithaca New York, and The Miller School of Medicine at the University of Miami in Miami, Florida. She was trained in internal medicine at Massachusetts’s General Hospital and completed her gastroenterology fellowship training at Brigham and Women’s Hospital. She later went on to receive a Master of Public Health degree from the Harvard School of Public Health.
Currently she is an attending gastroenterologist at the Brigham and Women’s Hospital Crohn’s and Colitis Center, where she also serves as the center’s Director of Clinical Trials. In addition to her clinical responsibilities, Dr. Allegretti is the director of the fecal microbiota transplant program at Brigham and Women’s Hospital. She is currently leading several clinical trials investigating the use of fecal transplantation in several chronic diseases such as Inflammatory Bowel Disease, Primary Sclerosing Cholangitis and obesity. Additionally, Dr. Allegretti’s lab focuses on investigating the mechanisms of recurrent clostridium difficile infections.
Posts by Jessica Allegretti, MD, MPH

Infectious diseases
New donor screening protocols for clinical trials involving fecal microbiota transplantation

Jessica Allegretti, MD, MPH